Clinical Trials on Mixed Dyslipidemias in Netherlands

Total 191 results

GlaxoSmithKline

Completed

GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol

Dyslipidaemia | Dyslipidaemias

Germany, Estonia, Belgium, France, Netherlands, Denmark, Portugal, Norway, Sweden, Lithuania, Finland
Amgen

Completed

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia (OSLER-2)

Hyperlipidemia and Mixed Dyslipidemia

United States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
Maastricht University Medical Center
DSM Nutritional Products, Inc.

Completed

Resveratrol and Serum Apo A-I

Dyslipidemia

Netherlands
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Dyslipidemia

Netherlands
Akros Pharma Inc.

Completed

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Dyslipidemia

Netherlands
Maastricht University Medical Center
Top Institute Food and Nutrition

Completed

Beetroot Juice and Postprandial Vascular Activity

Dyslipidemia

Netherlands
Maastricht University Medical Center
Unilever R&D

Completed

Saturated Fatty Acids and HDL Metabolism

Dyslipidemia

Netherlands
Leiden University Medical Center
Dutch Diabetes Research Foundation

Completed

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans

Insulin Resistance | Dyslipidemia

Netherlands
Leiden University Medical Center
Dutch Diabetes Research Foundation

Completed

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans

Insulin Resistance | Dyslipidemia

Netherlands
Erasmus Medical Center
Dutch Heart Foundation

Completed

CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners

Decision Support Systems, Clinical

Netherlands
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects (ASSIST)

Metabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Metabolic Disorder

Netherlands
Xention Ltd

Completed

TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) (TULIP)

Dyslipidemia

Denmark, Netherlands
NewAmsterdam Pharma

Completed

Randomized Study of Obicetrapib in Combination With Ezetimibe (OCEAN)

Dyslipidemias | Hypercholesterolemia | High Cholesterol

United States, Netherlands
Radboud University Medical Center

Unknown

Cardiovascular Effects of Salvia Miltiorrhiza Extract (Danshen)

Inflammation | Hypertension | Dyslipidemias | Oxidative Stress | Vasodilation

Netherlands
Amgen

Completed

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a)) (ANITSCHKOW)

Subjects With Hyperlipidemia, Dyslipidemia

Canada, Netherlands, United States
Silence Therapeutics plc
Medpace, Inc.

Completed

Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)

Dyslipidemias | Hyperlipidemias | Elevated Lp(a)

United States, Australia, United Kingdom, Netherlands
Kowa Research Europe

Completed

Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients

Hypercholesterolemia or Combined Dyslipidemia

Denmark, Israel, Netherlands, Germany, United Kingdom
Sanofi

Terminated

European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia (ETERNAL)

Obesity | Dyslipidemias

Germany, Netherlands, Turkey, Slovakia, United Kingdom, Finland, Hungary, Ireland, Italy, Norway, Greece, Sweden, Czech Republic, Portugal, Switzerland
Arrowhead Pharmaceuticals

Active, not recruiting

Study of ARO-APOC3 in Adults With Dyslipidemia

Dyslipidemias

United States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
Kowa Research Europe

Completed

Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

Dyslipidemias | Hypercholesterolemia

Denmark, Israel, Germany, Netherlands, United Kingdom
Kowa Research Europe

Completed

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

Dyslipidemia | Hypercholesterolemia

Spain, Sweden, Denmark, Netherlands
Takeda

Completed

Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

Dyslipidemia

United States, Germany, Argentina, Mexico, Poland, South Africa, Chile, Netherlands, Peru, Estonia, Russian Federation, Czech Republic, Hungary, Lithuania, Latvia, Slovakia, United Kingdom
Amgen

Completed

Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects (EBBINGHAUS)

Dyslipidemia

United States, Belgium, Denmark, Finland, France, Italy, Spain, Hungary, Poland, Germany, Czechia, Turkey, United Kingdom, Malaysia, Australia, Hong Kong, New Zealand, Canada, South Africa, Greece, Portugal, Netherlands, Russian Federation and more
Kowa Research Europe

Completed

Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

Dyslipidemia | Hypercholesterolemia

Spain, Denmark, India, Israel, Sweden, Finland, Germany, Italy, Netherlands, Norway, Poland, Russian Federation, United Kingdom
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration

Metabolic Diseases | Congenital Abnormalities | Infant, Newborn, Diseases | Genetic Diseases, Inborn | Dyslipidemias | Metabolism, Inborn Errors | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Lipid Metabolism, Inborn Errors | Hypobetalipoproteinemias | Hypolipoproteinemias | Hypolipopro... and other conditions

Netherlands
Amgen

Completed

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Dyslipidemia

United States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Czechia, Hungary, Taiwan, Colombia, Poland, Russian Federation, Switzerland, Korea, Republic of, Mexico, ... and more
Eli Lilly and Company

Completed

A Study of LY2484595 in Patients With High LDL-C or Low HDL-C

Dyslipidemia

United States, Netherlands, Germany, Denmark, Poland, United Kingdom
Kowa Research Europe

Completed

Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels

Dyslipidemia | Primary Hypercholesterolemia

Spain, Denmark, India, Israel, Sweden, Finland, Germany, Italy, Netherlands, Norway, Poland, Russian Federation, United Kingdom
Pfizer

Completed

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events (SPIRE-LL)

Hyperlipidemia

Finland, Netherlands, United States, Canada, Sweden, Korea, Republic of, Singapore, Czechia, Poland, United Kingdom, Puerto Rico, Norway
Oticon Medical
Statistiska Konsultgruppen

Completed

Clinical Survey of Oticon Medical Ponto Implants and a Surgical Technique With Tissue Preservation

Conductive Hearing Loss | Single Sided Deafness | Mixed Hearing Loss

Netherlands
Oticon Medical

Completed

Clinical Study of Minimally Invasive Ponto Surgical Technique (MIPS) - Design Iteration

Unilateral Deafness | Bone Conduction Deafness | Mixed Hearing Loss | Middle Ear Deafness

Netherlands
Wageningen University
Unilever R&D; Netherlands Heart Foundation

Completed

MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study

Hypertension | Overweight | Insulin Resistance | Dyslipidemia | Metabolic Syndrome X

Netherlands
Radboud University Medical Center

Completed

Effectiveness of Insignia ™ Versus Standard Orthodontic Treatment With Damon Q Brackets

Orthodontic Treatment | Fixed Appliances | Insignia | DamonQ Brackets

Netherlands
AstraZeneca

Completed

The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

Hypercholesterolemia

Netherlands
Oticon Medical

Completed

Clinical Survey of Minimally Invasive Ponto Surgical Technique (MIPS)

Unilateral Deafness | Bone Conduction Deafness | Mixed Hearing Loss | Middle Ear Deafness

Netherlands
Santaris Pharma A/S

Terminated

Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH

Hypercholesterolemia

Netherlands
Boehringer Ingelheim

Completed

Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia

Hypertension | Dyslipidemias

Taiwan, Netherlands, Czech Republic, France, Germany, Hong Kong, Korea, Republic of, Russian Federation, Slovakia, South Africa, Sweden, Ukraine
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Long Term Effects of Plant Sterol and Stanol Esters (LTS)

Hypercholesterolemia

Netherlands
Utrecht Institute for Pharmaceutical Sciences
Harvard University; Scientific Institute for Dutch Pharmacists, The Netherlands and other collaborators

Completed

A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering Treatment

Hypercholesterolemia

Netherlands
Solvay Pharmaceuticals

Terminated

Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI

Dyslipidemia | Glucose Metabolism Disorder

Poland, Croatia, Finland, France, Germany, Netherlands, Romania, Ukraine
Maastricht University Medical Center

Completed

Gut Flora and Lipid Metabolism

Hypercholesterolemia

Netherlands
Maastricht University Medical Center
Raisio Group

Completed

Plant Stanols and Gene Expression Profile

Hypercholesterolemia

Netherlands
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Academisch...

Recruiting

Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes

Insulin Resistance | Hypertriglyceridemia

Netherlands
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin. (AVIATOR)

HIV | Hypercholesterolaemia

Netherlands
Kowa Research Europe

Completed

Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

Dyslipidemia | Type II Diabetes Mellitus

India, Denmark, Germany, Netherlands, Poland, United Kingdom
Oticon Medical

Active, not recruiting

Clinical Investigation Study of Safety and Performance of the Sentio System.

Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, Mixed

Germany, Netherlands, United Kingdom
Maastricht University Medical Center
Nederlandse Zuivel Organisatie

Completed

Postprandial Effects of Milk and Milk Constituents

Inflammation | Hyperlipidemia

Netherlands
Kowa Research Europe

Completed

Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

Dyslipidemia | Type II Diabetes Mellitus

India, Germany, Netherlands, Poland, Denmark, United Kingdom
UMC Utrecht
Isala; Medrie Health Care Group, Zwolle; Hein Hogerzeil Stichting

Unknown

The ZWOlle Transmural Integrated Care for CArdiovaScular Risk Management Study (ZWOT-CASE)

Cardiovascular Diseases | Hypertension | Hypercholesterolemia

Netherlands
Maastricht University Medical Center

Completed

Effects of Buttermilk on Serum LDL Cholesterol Concentrations

Cardiovascular Disease | Hypercholesterolemia | Dietary Modification | Buttermilk

Netherlands

Clinical Trials on Mixed Dyslipidemias in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations